Brett Icahn - 30 Jun 2025 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Jul 2025, 16:38:51 UTC
Prior SEC filing
02 Jun 2025
Next SEC filing
05 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brianna M. Cetrulo, attorney-in-fact

Key filing fact

Brett Icahn filed Form 4 for Bausch Health Companies Inc. (BHC) on 02 Jul 2025.

Key facts

  • This page summarizes Brett Icahn's Form 4 filing for Bausch Health Companies Inc. (BHC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jul 2025, 16:38.

Change

  • Previous filing in this sequence was filed on 02 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001387184 Primary reporting owner

ICAHN BRETT

Relationship
Director
Address
400 SOMERSET CORPORATE BLVD, BRIDGEWATER
Signature
/s/ Brianna M. Cetrulo, attorney-in-fact
Signature date
02 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BHC transaction

Common Shares, No Par Value

Award

Transaction value
$0
Shares
+4,034
Change %
+1.9%
Price
$0.000000
Shares after
220,280
Date
30 Jun 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .